Vanguard Global Advisers’s Vericel VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$801K Buy
19,961
+1,229
+7% +$53.2K ﹤0.01% 1856
2026
Q2
$833K Sell
18,732
-1,172
-6% -$42.2K ﹤0.01% 1847
2026
Q1
$640K Buy
+19,904
New +$707K ﹤0.01% 1922

Other funds holding VCEL

Vanguard Global Advisers's VCEL Position: Q3 2026 in Review

Vanguard Global Advisers increased its Vericel (VCEL) stake by 6.6% in Q3 2026, buying an estimated $53.2K and bringing the position to 19,961 shares worth $801K. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

Vanguard Global Advisers first reported a position in VCEL in Q1 2026 and has held it in 3 quarters since. The position peaked at $833K in Q2 2026. 284 funds tracked by Wall St. Rank hold VCEL as of Q3 2026.

  • Vanguard Global Advisers held 19,961 shares of Vericel worth $801K as of Q3 2026.
  • Vanguard Global Advisers bought 1,229 Vericel shares in Q3 2026, an estimated $53.2K.
  • Vericel made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1856 holding.
  • Vanguard Global Advisers first reported a position in Vericel in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Vericel position peaked at $833K in Q2 2026.
  • 284 funds tracked by Wall St. Rank held Vericel as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.